Auditory and imaging markers of atypical enlarged vestibular aqueduct

Eur Arch Otorhinolaryngol. 2022 Feb;279(2):695-702. doi: 10.1007/s00405-021-06700-0. Epub 2021 Mar 9.

Abstract

Purpose: To characterize the auditory and imaging markers of atypical enlarged vestibular aqueduct (EVA).

Methods: 15 EVA cases (26 ears) confirmed via high-resolution MRI (HRMRI) that did not meet the Valvassori criterion on high-resolution CT (HRCT) were classified as atypical EVA. Another 21 EVA cases (40 ears) meeting the Valvassori criterion were randomly chosen as typical EVA. The hearing loss (HL), HRCT, and HRMRI findings were compared between the two groups.

Results: The difference of HL severity between atypical and typical EVA was not statistically significant (χ2 = 0.12, P > 0.05. The vestibular aqueducts (VA) of atypical EVA cases manifested as borderline dilation (n = 17), focal dilation (n = 3), and normal appearance (n = 6) on the HRCT. The midpoint width of atypical and typical EVA cases was 1.06 ± 0.18 mm and 2.10 ± 0.55 mm, respectively, exhibiting a significant difference (t = - 9.20, P < 0.05). In the HRMRI, the degree of dilation and shape of the intraosseous partition of endolymphatic duct and sac (ES) was similar to that of VA on HRCT, while their extraosseous ES was depicted variable slighter dilation compared to that of typical one, the difference between them was statistically significant (t = - 4.10, P < 0.05).

Conclusion: The HL severity of atypical EVA ears was similar to that of typical ones. Nevertheless, borderline, focal dilation and normal-like appearance of VAs on HRCT and variablely slighter dilation of the extraosseous ES on HRMRI are its characteristic imaging findings.

Keywords: Atypical; Enlarged vestibular aqueduct; Magnetic resonance imaging; Tomography; X-ray computed.

MeSH terms

  • Endolymphatic Duct
  • Hearing Loss, Sensorineural*
  • Humans
  • Retrospective Studies
  • Vestibular Aqueduct* / abnormalities
  • Vestibular Aqueduct* / diagnostic imaging

Supplementary concepts

  • Deafness, Autosomal Recessive 4